Author:
Galderisi Silvana,Giordano Giulia Maria,DeLisi Lynn E.
Publisher
Springer International Publishing
Reference265 articles.
1. Lawrie SM, McIntosh AM, Hall J, Owens DG, Johnstone EC. Brain structure and function changes during the development of schizophrenia: the evidence from studies of subjects at increased genetic risk. Schizophr Bull. 2008;34(2):330–40. https://doi.org/10.1093/schbul/sbm158 .
2. Moorhead TW, Stanfield AC, McKechanie AG, Dauvermann MR, Johnstone EC, Lawrie SM, Cunningham Owens DG. Longitudinal gray matter change in young people who are at enhanced risk of schizophrenia due to intellectual impairment. Biol Psychiatry. 2013;73(10):985–92. https://doi.org/10.1016/j.biopsych.2012.12.011 .
3. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89–95. https://doi.org/10.1067/mcp.2001.113989 .
4. The Food and Drug Modernization Act. Title 21 Code of Federal Regulations Part 314 Subpart H Section 314.500. 1997.
5. First M, Botteron K, Carter C, Castellanos FX, Dickstein DP, Drevets W, Kim KL, Pescosolido MF, Raush S, Seymour KE, Sheline Y, Zubieta J-K. Consensus report of the APA work group on neuroimaging markers of psychiatric disorders. Virginia: American Psychiatric Association; 2012.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献